Basic Information
| LncRNA/CircRNA Name | NAMA |
| Synonyms | NAMA |
| Region | GRCh38_9:99355337-99377240 |
| Ensemble | ENSG00000271086 |
| Refseq | NR_102270 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | qPCR, RNAi, Western blot, Northern blot etc. |
| Sample | PTA tissues tissues, cell lines (NPA87, K1, K2 etc.) |
| Expression Pattern | down-regulated |
| Function Description | The downregulation of NAMA in PTCs with the BRAF*V600E mutation led us to test whether NAMA is regulated by the MAP kinase pathway. We suggest that NAMA is a noncoding RNA associated with growth arrest. |
| Pubmed ID | 17415708 |
| Year | 2007 |
| Title | Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. |
External Links
| Links for NAMA | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |